{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:57:17Z","timestamp":1793969837920,"version":"4.8.0"},"reference-count":20,"publisher":"Chinese Center for Disease Control and Prevention","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.46234\/ccdcw2023.129","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:15:42Z","timestamp":1690776942000},"page":"664-671","source":"Crossref","is-referenced-by-count":63,"title":["Changes in HIV-1 Subtypes\/Sub-Subtypes, and Transmitted Drug Resistance Among ART-Na\u00efve HIV-Infected Individuals \u2014 China, 2004\u20132022"],"prefix":"10.46234","volume":"5","author":[{"given":"Xiu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25413","reference":[{"key":"1","unstructured":"UNAIDS. Global HIV &amp; AIDS statistics \u2014 fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet. [2023-04-20]."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Wittkop L, G\u00fcnthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, De Luca A, et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 2011;11(5):363 \u2212 71.  http:\/\/dx.doi.org\/10.1016\/S1473-3099(11)70032-9.","DOI":"10.1016\/S1473-3099(11)70032-9"},{"key":"3","unstructured":"Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. <a href=\"https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/adult-adolescent-arv\/guidelines-adult-adolescent-arv.pdf\">https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/adult-adolescent-arv\/guidelines-adult-adolescent-arv.pdf<\/a>. [2022-4-10]."},{"key":"4","unstructured":"European AIDS Clinical Society. Guidelines version 10.0. 2019. <a href=\"https:\/\/www.eacsociety.org\/files\/2019_guidelines-10.0_final.pdf\">https:\/\/www.eacsociety.org\/files\/2019_guidelines-10.0_final.pdf<\/a>. [2020-3-13]."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ma Y, Dou ZH, Guo W, Mao YR, Zhang FJ, McGoogan JM, et al. The human immunodeficiency virus care continuum in China: 1985\u20132015. Clin Infect Dis 2018;66(6):833 \u2212 9.  http:\/\/dx.doi.org\/10.1093\/cid\/cix911.","DOI":"10.1093\/cid\/cix911"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Rose R, Cross S, Lamers SL, Astemborski J, Kirk GD, Mehta SH, et al. Persistence of HIV transmission clusters among people who inject drugs. AIDS 2020;34(14):2037 \u2212 44.  http:\/\/dx.doi.org\/10.1097\/QAD.0000000000002662.","DOI":"10.1097\/QAD.0000000000002662"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 2020;37(5):1530 \u2212 4.  http:\/\/dx.doi.org\/10.1093\/molbev\/msaa015.","DOI":"10.1093\/molbev\/msaa015"},{"key":"8","unstructured":"World Health Organization. Surveillance of HIV drug resistance in populations initiating antiretroviral therapy (pre-treatment HIV drug resistance): concept note. Geneva: World Health Organization. 2014. <a href=\"https:\/\/apps.who.int\/iris\/handle\/10665\/112802\">https:\/\/apps.who.int\/iris\/handle\/10665\/112802<\/a>."},{"key":"9","unstructured":"World Health Organization. HIV drug resistance report 2021. Geneva: World Health Organization. 2021. <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240038608\">https:\/\/www.who.int\/publications\/i\/item\/9789240038608<\/a>."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis 2019;19(2):143 \u2212 55.  http:\/\/dx.doi.org\/10.1016\/S1473-3099(18)30647-9.","DOI":"10.1016\/S1473-3099(18)30647-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Xu JJ, Han MJ, Jiang YJ, Ding HB, Li X, Han XX, et al. Prevention and control of HIV\/AIDS in China: lessons from the past three decades. Chin Med J 2021;134(23):2799 \u2212 809.  http:\/\/dx.doi.org\/10.1097\/CM9.0000000000001842.","DOI":"10.1097\/CM9.0000000000001842"},{"key":"12","doi-asserted-by":"crossref","unstructured":"He X, Xing H, Ruan YH, Hong KX, Cheng CL, Hu YY, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One 2012;7(10):e47289.  http:\/\/dx.doi.org\/10.1371\/journal.pone.0047289.","DOI":"10.1371\/journal.pone.0047289"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 2008;13 Suppl 2:25 \u2212 36.  http:\/\/dx.doi.org\/10.1177\/135965350801302s04.","DOI":"10.1177\/135965350801302S04"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Zuo LL, Liu K, Liu HL, Hu YH, Zhang ZJ, Qin JR, et al. Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001\u20132017). eClinicalMedicine 2020;18:100238.  http:\/\/dx.doi.org\/10.1016\/j.eclinm.2019.100238.","DOI":"10.1016\/j.eclinm.2019.100238"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Rhee SY, Kassaye SG, Barrow G, Sundaramurthi JC, Jordan MR, Shafer RW. HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates. J Int AIDS Soc 2020;23(9):e25611.  http:\/\/dx.doi.org\/10.1002\/jia2.25611.","DOI":"10.1002\/jia2.25611"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009;4(3):e4724.  http:\/\/dx.doi.org\/10.1371\/journal.pone.0004724.","DOI":"10.1371\/journal.pone.0004724"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Rhee SY, Clutter D, Fessel WJ, Klein D, Slome S, Pinsky BA, et al. Trends in the molecular epidemiology and genetic mechanisms of transmitted human immunodeficiency virus type 1 drug resistance in a large US clinic population. Clin Infect Dis 2019;68(2):213 \u2212 21.  http:\/\/dx.doi.org\/10.1093\/cid\/ciy453.","DOI":"10.1093\/cid\/ciy453"},{"key":"18","doi-asserted-by":"crossref","unstructured":"McClung RP, Oster AM, Ocfemia MCB, Saduvala N, Heneine W, Johnson JA, et al. Transmitted drug resistance among Human Immunodeficiency Virus (HIV)-1 diagnoses in the United States, 2014\u20132018. Clin Infect Dis 2022;74(6):1055 \u2212 62.  http:\/\/dx.doi.org\/10.1093\/cid\/ciab583.","DOI":"10.1093\/cid\/ciab583"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Walter H, Schmidt B, Korn K, Vandamme AM, Harrer T, \u00dcberla K. Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J Clin Virol 1999;13(1 \u2212 2):71 \u2212 80.  http:\/\/dx.doi.org\/10.1016\/s1386-6532(99)00010-4.","DOI":"10.1016\/S1386-6532(99)00010-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"De Cock KM, Jaffe HW, Curran JW. Reflections on 40 years of AIDS. Emerg Infect Dis 2021;27(6):1553 \u2212 60.  http:\/\/dx.doi.org\/10.3201\/eid2706.210284.","DOI":"10.3201\/eid2706.210284"}],"container-title":["China CDC Weekly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/weekly.chinacdc.cn\/en\/article\/pdf\/preview\/10.46234\/ccdcw2023.129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:15:52Z","timestamp":1690776952000},"score":1,"resource":{"primary":{"URL":"https:\/\/weekly.chinacdc.cn\/en\/article\/doi\/10.46234\/ccdcw2023.129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.46234\/ccdcw2023.129","relation":{},"ISSN":["2097-3101"],"issn-type":[{"value":"2097-3101","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}